Geldanamycin

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameGeldanamycin
Drug Alias NameNSC-122750
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionHeat-shock protein inhibitorsProtein-tyrosine kinases inhibitors
TargetsProtein-tyrosine kinasesHeat-shock protein
Therapy Area/IndicationsNeoplasmsHerpes Simplex
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomMainland China
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaDiscontinued
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc +[2] 
Active IndicationsN/A
Inactive IndicationsNeoplasmsHerpes Simplex

Other Information

ATC CodeN/A
Related LinksN/A